Last update 15 Feb 2025

Amlodipine/Losartan/Rosuvastatin/Ezetimibe

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Amlodipine/ezetimibe/losartan/rosuvastatin, HCP 1701, HCP-1701
Target
AT1R x HMGCR x NPC1L1 x VDCCs
Mechanism
AT1R antagonists(Angiotensin II Receptor Type 1 antagonists), HMG-CoA reductase inhibitors(HMG-CoA reductase inhibitors), NPC1L1 inhibitors(Niemann-Pick C1-like protein 1 inhibitors)
Therapeutic Areas
Cardiovascular DiseasesEndocrinology and Metabolic Disease
Active Indication
DyslipidemiasHypertension
Inactive Indication-
Originator Organization
Hanmi Pharmaceutical Co., Ltd.Hanmi Pharmaceutical Co., Ltd.
Active Organization
Hanmi Pharmaceutical Co., Ltd.Hanmi Pharmaceutical Co., Ltd.
Inactive Organization-
Drug Highest PhaseApproved
First Approval Date-
Regulation-
Login to view timeline

Structure/Sequence

Molecular FormulaC22H23ClKN6O
InChIKeyFDKIDFYIEWFERB-UHFFFAOYSA-N
CAS Registry124750-99-8
View All Structures (4)

Related

2
Clinical Trials associated with Amlodipine/Losartan/Rosuvastatin/Ezetimibe
NCT04074551
/ CompletedPhase 3
A Randomized, Double-blinded, Multi-center, Phase III Study to Compare The Efficacy and Safety of Co-administered HGP0608, HGP0904 and HCP1306 Versus HCP1701 in Patients With Hypertension and Dyslipidemia
NCT04322266
/ CompletedPhase 1
An Open-Label, Randomized, Single-Dose Crossover Study to Compare the Pharmacokinetics, Safety and Tolerability Between Fixed-Dose Combination and Co-Administration of HGP0904, HGP0608 and HCP1306 Tablets in Healthy Male Subjects
100 Clinical Results associated with Amlodipine/Losartan/Rosuvastatin/Ezetimibe
Login to view more data
100 Translational Medicine associated with Amlodipine/Losartan/Rosuvastatin/Ezetimibe
Login to view more data
100 Patents (Medical) associated with Amlodipine/Losartan/Rosuvastatin/Ezetimibe
Login to view more data
100 Deals associated with Amlodipine/Losartan/Rosuvastatin/Ezetimibe
Login to view more data

R&D Status

10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Dyslipidemias
KR
Hanmi Pharmaceutical Co., Ltd.Hanmi Pharmaceutical Co., Ltd.
-
Hypertension
KR
Hanmi Pharmaceutical Co., Ltd.Hanmi Pharmaceutical Co., Ltd.
-
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free